334 related articles for article (PubMed ID: 26610860)
1. A longitudinal analysis of chronic MRSA and Pseudomonas aeruginosa co-infection in cystic fibrosis: A single-center study.
Maliniak ML; Stecenko AA; McCarty NA
J Cyst Fibros; 2016 May; 15(3):350-6. PubMed ID: 26610860
[TBL] [Abstract][Full Text] [Related]
2. Bronchopulmonary infection-colonization patterns in Spanish cystic fibrosis patients: Results from a national multicenter study.
de Dios Caballero J; Del Campo R; Royuela A; Solé A; Máiz L; Olveira C; Quintana-Gallego E; de Gracia J; Cobo M; de la Pedrosa EG; Oliver A; Cantón R;
J Cyst Fibros; 2016 May; 15(3):357-65. PubMed ID: 26429520
[TBL] [Abstract][Full Text] [Related]
3. Multicenter Observational Study on Factors and Outcomes Associated with Various Methicillin-Resistant Staphylococcus aureus Types in Children with Cystic Fibrosis.
Muhlebach MS; Heltshe SL; Popowitch EB; Miller MB; Thompson V; Kloster M; Ferkol T; Hoover WC; Schechter MS; Saiman L;
Ann Am Thorac Soc; 2015 Jun; 12(6):864-71. PubMed ID: 25745825
[TBL] [Abstract][Full Text] [Related]
4. Association between Staphylococcus aureus alone or combined with Pseudomonas aeruginosa and the clinical condition of patients with cystic fibrosis.
Hubert D; Réglier-Poupet H; Sermet-Gaudelus I; Ferroni A; Le Bourgeois M; Burgel PR; Serreau R; Dusser D; Poyart C; Coste J
J Cyst Fibros; 2013 Sep; 12(5):497-503. PubMed ID: 23291443
[TBL] [Abstract][Full Text] [Related]
5. Microbial colonization and lung function in adolescents with cystic fibrosis.
Hector A; Kirn T; Ralhan A; Graepler-Mainka U; Berenbrinker S; Riethmueller J; Hogardt M; Wagner M; Pfleger A; Autenrieth I; Kappler M; Griese M; Eber E; Martus P; Hartl D
J Cyst Fibros; 2016 May; 15(3):340-9. PubMed ID: 26856310
[TBL] [Abstract][Full Text] [Related]
6. Respiratory pathogens mediate the association between lung function and temperature in cystic fibrosis.
Collaco JM; Raraigh KS; Appel LJ; Cutting GR
J Cyst Fibros; 2016 Nov; 15(6):794-801. PubMed ID: 27296562
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for persistent methicillin-resistant Staphylococcus aureus infection in cystic fibrosis.
Jennings MT; Dasenbrook EC; Lechtzin N; Boyle MP; Merlo CA
J Cyst Fibros; 2017 Nov; 16(6):681-686. PubMed ID: 28446387
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics and epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) in children with cystic fibrosis from a center with a high MRSA prevalence.
Harik NS; Com G; Tang X; Melguizo Castro M; Stemper ME; Carroll JL
Am J Infect Control; 2016 Apr; 44(4):409-15. PubMed ID: 26684366
[TBL] [Abstract][Full Text] [Related]
9. Impact of colonizing organism in the respiratory tract on the incidence, duration, and time between subsequent hospitalizations among patients with cystic fibrosis.
Cios K; Cohen B; Quittell LM; Liu J; Larson EL
Am J Infect Control; 2019 Jul; 47(7):750-754. PubMed ID: 30732978
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal changes and regional variation of incident infection rates at cystic fibrosis centers, United States 2010-2016.
Muhlebach MS; Jiang X; Kosorok MR; Klein EY; Saiman L
J Cyst Fibros; 2022 Jan; 21(1):34-39. PubMed ID: 34456157
[TBL] [Abstract][Full Text] [Related]
11. Comparison of intravenous and non-intravenous antibiotic regimens in eradication of P. aeruginosa and MRSA in cystic fibrosis.
Mursaloglu HH; Akın C; Yılmaz Yeğit C; Ergenekon AP; Suzer Uzunoglu B; Taştan G; Gökdemir Y; Erdem Eralp E; Karahasan Yağcı A; Karakoç F; Karadağ B
Pediatr Pulmonol; 2021 Dec; 56(12):3745-3751. PubMed ID: 34436829
[TBL] [Abstract][Full Text] [Related]
12. Staphylococcus aureus in the airways of cystic fibrosis patients - A retrospective long-term study.
Schwerdt M; Neumann C; Schwartbeck B; Kampmeier S; Herzog S; Görlich D; Dübbers A; Große-Onnebrink J; Kessler C; Küster P; Schültingkemper H; Treffon J; Peters G; Kahl BC
Int J Med Microbiol; 2018 Aug; 308(6):631-639. PubMed ID: 29501453
[TBL] [Abstract][Full Text] [Related]
13. Seasonality of acquisition of respiratory bacterial pathogens in young children with cystic fibrosis.
Psoter KJ; De Roos AJ; Wakefield J; Mayer JD; Rosenfeld M
BMC Infect Dis; 2017 Jun; 17(1):411. PubMed ID: 28599639
[TBL] [Abstract][Full Text] [Related]
14. Treatment intensity and characteristics of MRSA infection in CF.
Muhlebach MS; Miller M; LaVange LM; Mayhew G; Goodrich JS; Miller MB
J Cyst Fibros; 2011 May; 10(3):201-6. PubMed ID: 21420912
[TBL] [Abstract][Full Text] [Related]
15. The changing prevalence of pulmonary infection in adults with cystic fibrosis: A longitudinal analysis.
Ramsay KA; Sandhu H; Geake JB; Ballard E; O'Rourke P; Wainwright CE; Reid DW; Kidd TJ; Bell SC
J Cyst Fibros; 2017 Jan; 16(1):70-77. PubMed ID: 27515017
[TBL] [Abstract][Full Text] [Related]
16. Outcomes and Treatment of Chronic Methicillin-Resistant Staphylococcus aureus Differs by Staphylococcal Cassette Chromosome mec (SCCmec) Type in Children With Cystic Fibrosis.
Heltshe SL; Saiman L; Popowitch EB; Miller MB; Kloster M; Thompson V; Ferkol TW; Hoover WC; Schechter MS; Muhlebach MS
J Pediatric Infect Dis Soc; 2015 Sep; 4(3):225-31. PubMed ID: 26336603
[TBL] [Abstract][Full Text] [Related]
17. Molecular epidemiology of Pseudomonas aeruginosa, Burkholderia cepacia complex and methicillin-resistant Staphylococcus aureus in a cystic fibrosis center.
Campana S; Taccetti G; Ravenni N; Masi I; Audino S; Sisi B; Repetto T; Döring G; de Martino M
J Cyst Fibros; 2004 Aug; 3(3):159-63. PubMed ID: 15463902
[TBL] [Abstract][Full Text] [Related]
18. Persistent methicillin-resistant Staphylococcus aureus and rate of FEV1 decline in cystic fibrosis.
Dasenbrook EC; Merlo CA; Diener-West M; Lechtzin N; Boyle MP
Am J Respir Crit Care Med; 2008 Oct; 178(8):814-21. PubMed ID: 18669817
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and impact on FEV(1) decline of chronic methicillin-resistant Staphylococcus aureus (MRSA) colonization in patients with cystic fibrosis. A single-center, case control study of 165 patients.
Vanderhelst E; De Meirleir L; Verbanck S; Piérard D; Vincken W; Malfroot A
J Cyst Fibros; 2012 Jan; 11(1):2-7. PubMed ID: 21907637
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes after initial pseudomonas acquisition in cystic fibrosis.
Zemanick ET; Emerson J; Thompson V; McNamara S; Morgan W; Gibson RL; Rosenfeld M;
Pediatr Pulmonol; 2015 Jan; 50(1):42-8. PubMed ID: 24644274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
